Showing results (51-60 of 693) with videos related to

Sort By:
Pageof 70
Haematologica|July 2, 2013
Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 monthsAziz Nazha, Hagop Kantarjian, Preetesh Jain, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2023
SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?Shaoying Li, Guilin Tang, Preetesh Jain, et al.
International Journal of Cancer|July 20, 2017
Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Blood|September 14, 2011
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaXiao-Jie Yan, Igor Dozmorov, Wentian Li, et al.
The Lancet. Haematology|December 22, 2015
Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trialsKoji Sasaki, Sara S Strom, Susan O'Brien, et al.
Clinical Case Reports|August 16, 2016
Successful treatment of aplastic anemia-paroxysmal nocturnal hemoglobinuria associated with eosinophilic fasciitis with matched unrelated donor allogeneic peripheral blood stem cell transplantationKoji Sasaki, Uday Popat, Preetesh Jain, et al.
Nature Communications|July 2, 2026
BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistanceSoo-Yeon Hwang, Xiangao Huang, Helgi Nikolli, et al.
Human Pathology|May 17, 2025
Optical genome mapping reveals diverse mechanisms of cyclin activation in mantle cell lymphomas lacking IGH::CCND1Guilin Tang, Preetesh Jain, Shimin Hu, et al.
Leukemia & Lymphoma|October 14, 2014
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomesOhad Benjamini, Preetesh Jain, Long Trinh, et al.
Blood|April 27, 2013
Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalitiesPreetesh Jain, Hagop Kantarjian, Aziz Nazha, et al.
Pageof 70